垂体卒中后视觉恢复中干预时机与治疗方式的作用:系统综述与Meta分析
该系统综述与Meta分析检索PubMed、Scopus和Embase数据库,纳入29项研究,评估垂体卒中后早期与延迟手术(48小时、72小时、7天三个时间界值)对视觉结局的影响,以及手术减压与保守治疗的疗效比较。Meta分析显示,7天内手术减压的患者视觉结局显著优于7天后手术(OR 5.88,95%CI [1.77, 19.60],I²=0%,p<0.01);手术与保守治疗比较差异无统计学意义(p>0.05)。
要点
- 7天内手术减压的患者视觉结局显著优于7天后手术(OR 5.88,95%CI [1.77, 19.60],I²=0%,p<0.01)。
- 手术与保守治疗垂体卒中的视觉结局比较差异无统计学意义(p>0.05)。
- 作者认为伴严重视觉缺损或意识改变的垂体卒中最好在就诊后7天内处理,手术与保守治疗结局相似。
核心结论
- 垂体卒中的手术干预时机仅在7天时间点对视觉功能恢复有预测价值,与既往研究报道一致。
- 作者认为伴严重视觉缺损或意识改变的垂体卒中最好在就诊后7天内处理,手术与保守治疗可提供相似结局。
- 作者建议怀疑垂体卒中时,无论急性程度或严重程度均应给予静脉糖皮质激素以预防继发性肾上腺危象。
- 作者建议对无严重视觉或其他神经功能缺损的患者采用期待管理,管理应个体化并取决于起病时症状严重程度。
研究设计与样本
- 系统综述与Meta分析,遵循PRISMA指南检索PubMed、Scopus和Embase数据库。
- 定量Meta分析采用Mantel-Haenszel方法,森林图使用Review Manager v5.4生成,P值<0.05定义为统计学显著性阈值。
- 初检和筛选后29项研究合格,包括16项描述干预时机作用和15项比较干预方式的研究。
- 7天界值亚分析纳入220例患者;48小时前手术减压81例,48-72小时手术减压32例。
- 手术与保守治疗比较的亚分析共纳入15项研究288例患者。
主要发现
- 大多数患者表现为视觉缺损,所有患者均接受手术,最常用经鼻内镜(EEA)入路。
- 几乎所有患者减压后视觉改善,包括72小时后队列19/19例(100%)。
- Mantel-Haenszel法Meta分析显示,7天前手术减压与7天后相比视觉结局差异显著,利于7天前手术(OR 5.88,95%CI [1.77, 19.60],I²=0%,p<0.01)。
- 手术与保守治疗垂体卒中的比较在Meta分析中差异无统计学意义(p>0.05)。
临床怎么用
- 作者建议怀疑垂体卒中时,无论急性程度或严重程度均应给予静脉糖皮质激素以预防继发性肾上腺危象。
- 作者建议对无严重视觉或其他神经功能缺损的患者采用期待管理。
- 作者认为管理应个体化并取决于起病时症状严重程度。
- 作者认为伴严重视觉缺损或意识改变的垂体卒中最好在就诊后7天内处理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pituitary apoplexy has historically been considered an emergent condition that necessitates surgical intervention when there is acute symptomatic onset. This potentially serious condition often occurs in the setting of an underlying adenoma, cystic lesion, or other sellar mass. When these mass lesions hemorrhage within the confined space of the sella turcica, the pituitary gland is subjected to hemorrhagic ischemia. Furthermore, critical neurovasculature in close proximity to the sella can sustain collateral damage. In the present study, we investigate whether early versus delayed surgical intervention (in terms of three timelines: before versus after 48 h, 72 h, and 7 days, respectively) results in differences in visual outcomes for patients experiencing pituitary apoplexy with acute onset neurological and/or neuro-opthalmic symptoms. Furthermore, we compare the efficacy of surgical decompression versus expectant management of this condition. METHODS: Accordingly, we queried the PubMed, Scopus, and Embase databases in adherence to PRISMA guidelines. Quantitative meta-analysis was performed according to the Mantel-Haenszel method and forest plots were generated using Review Manager v5.4. P-values < 0.05 were defined as the threshold for statistical significance. RESULTS: Twenty-nine studies remained eligible for review following initial search and screen, including 16 studies describing the role of intervention timing and 15 studies comparing intervention modality. Most patients presented with a visual deficit, and all patients underwent surgery - most commonly via the endoscopic endonasal (EEA) approach. Two hundred and twenty patients were included in the sub-analysis for the 7-day cutoff point. Furthermore, 81 patients underwent surgical decompression of the sella prior to 48 h, and 32 patients underwent surgical decompression between 48-72 h following presentation. Almost all patients exhibited improved vision post-decompression, including 19/19 patients (100%) in the post-72-h cohort. On meta-analysis using the Mantel-Haenszel method, there was a significant difference in vision outcomes in favor of patients who underwent surgical decompression before 7 days as compared to after seven days (OR 5.88, 95% CI [1.77, 19.60], I2 = 0%, p < 0.01). In a separate sub-analysis, there was a total of 288 patients across 15 studies comparing surgical versus conservative management of pituitary apoplexy. These management options proved equivocal on meta-analysis (p > 0.05). CONCLUSION: In the present study, timing of surgical intervention for pituitary apoplexy was predictive of visual function recovery only at the 7-day timepoint, as has been reported by previous studies. Ultimately, this suggests that pituitary apoplexy involving severe visual deficits or altered mental status is best addressed within the first seven days post-presentation, and that both surgery and conservative management can offer similar outcomes. When apoplexy is suspected, IV corticosteroids should be administered independent of acuity or severity to prevent secondary adrenal crisis. Subsequently, for patients presenting without severe visual or other neurological deficits, expectant management is recommended. Management should be patient-specific and dependent upon the severity of symptoms present at onset.
引用
- Brown NJ, Patel S, Gendreau J, et al. The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis. J Neurooncol. 2024. PMID: 39503840. doi:10.1007/s11060-024-04717-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。